|
Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11e
12/1/2008: New Advances in the Chemotherapy of Tuberculosis—Part 3 of 3: New Mechanisms Associated with Resistance to
Antituberculosis Drugs
Tawanda Gumbo
Division of Infectious Diseases, University of Texas Southwestern Medical Center, Dallas
Topics Discussed: adenosine triphosphate; antitubercular agents; chemotherapy regimen; dna gyrase; drug design and development; drug resistance; drug resistance, multiple; extrapulmonary tuberculosis; fluoroquinolones; isoniazid; multidrug efflux pump activity; multidrug-resistant tuberculosis; mycobacterium tuberculosis; mycolic acids; pharmacodynamics; pharmacokinetics; pharmacotherapy; pharmacotherapy of infectious diseases; pharmacotherapy of respiratory disorders; pyrazinamide; respiratory disorders; rifampin; streptomycin; therapy of microbial diseases; bacterial, viral, fungal, and protozoal infections; tuberculosis.
Related to Chapter 47. Chemotherapy of Tuberculosis, Mycobacterium avium Complex Disease, and Leprosy; View in chapter;
Excerpt:
"View in chapter..."
|
|
|
|
|